Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that data from an ongoing Phase II study (PNOC022, NCT05009992) of...

The ARK Group's legacy conference, KM Legal 2023, will return to Chicago on October 26-27. This year's program targets the full potential of artificial intelligence (AI) in knowledge management (KM).

From desert to mountain warfare, emergency response to disaster relief, RDS' tents feature rugged construction to support real-world expeditions. WASHINGTON, Ga., Sept. 29, 2023 /PRNewswire/ --...

TriNet (NYSE: TNET), a leading provider of comprehensive human resources solutions for small and medium-size businesses (SMBs), today announced that Kelly Tuminelli, TriNet's CFO, will be...

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced that Dr. Sam Barone, Chief Medical Officer, will give...